NextDocs snaps up $13.5 million in financing; Accelrys announces latest releases;

> An EU-backed project aims to use imaging and bioinformatics to understand the role of lipid metabolism in psychotic disorders. Article

> Accelrys ($ACCL) pledges to boost productivity in biotech research with the latest releases of its Direct, Chemical Registration and Biological Registration applications. Release

> Physicians have a lot of influence over which pharma websites patients visit, according to a study. Article

> SeaChange Pharmaceuticals has released software for matching drugs with disease targets based on multiple variables. Item

> NextDocs, a provider of content management software for life sciences groups, has reeled in $13.5 million in new financing. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.